{
    "body": "Which inherited disorder is known to be caused by mutations in the NEMO gene?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22036144", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19149237", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16532398", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18350553", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23378396", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22236433", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20434027", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20499091", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23405946", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17569396", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15833158", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22121116", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16104114", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24339369", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10911992"
    ], 
    "ideal_answer": [
        "Incontinentia pigmenti (IP) is a rare neurocutaneous disorder with a frequency of 1 in 50,000 newborn, and is associated with mutations in IKBKG gene (NEMO) in Xq28, inherited as an X-linked dominant trait", 
        "Incontinentia pigmenti (IP) or Bloch-Sulzberger syndrome (BSS) is a rare neurocutaneous disorder with a frequency of 1 in 50,000 newborn, and is associated with mutations in IKBKG gene (NEMO) in Xq28, inherited as an X-linked dominant trait."
    ], 
    "exact_answer": [
        "Incontinentia pigmenti or Bloch-Sulzberger syndrome"
    ], 
    "type": "factoid", 
    "id": "5721f4b30fd6f91b68000011", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 205, 
            "text": "Incontinentia pigmenti (IP) is a rare neurocutaneous disorder with a frequency of 1 in 50,000 newborn, and is associated with mutations in IKBKG gene (NEMO) in Xq28, inherited as an X-linked dominant trait", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22036144", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 615, 
            "offsetInEndSection": 754, 
            "text": "Mutations in the NEMO gene give rise to a heterogeneous group of disorders, including the X-linked dominant disorder incontinentia pigmenti", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20499091", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 92, 
            "text": "De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19149237", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 265, 
            "text": "Incontinentia pigmenti (IP) is a rare, inherited, multisystem genodermatosis. It is transmitted as an X-linked dominant trait. The disorder is a consequence of mutations in the NEMO gene (Xq28) that completely abolish expression of the NF-kappaB essential modulator", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19149237", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 536, 
            "text": "Incontinentia pigmenti (IP) is a rare inherited multisystem disorder characterized by a distinctive swirling pattern of the skin; defects of teeth, hair, and nails; and ophthalmic, central nervous system, and musculoskeletal abnormalities. It progresses through several well-defined stages. IP is transmitted as a dominant X-linked trait with variable expressivity, but many--if not most--cases are sporadic. IP has been shown to result from mutations in the NEMO gene that completely abolish expression of NF-kappaB essential modulator", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17569396", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 191, 
            "text": "Incontinentia pigmenti (IP; MIM308310) is a rare neurocutaneous X-dominant inherited disorder. Besides skin and neurological abnormalities, there is also ophthalmologic and dental involvement", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16104114", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 552, 
            "offsetInEndSection": 866, 
            "text": "The disorder is observed almost exclusively in girls, but diseased boys are more seriously affected. The IP gene is localised on chromosome Xq28. Mutations in the NEMO-gene are responsible for IP. This gene codes for the nuclear factor-KB essential modulator protein (NEMO; synonym: inhibitor kappaB kinase (IKK)y)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16104114", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 206, 
            "text": "Incontinentia pigmenti (IP) is an X-linked-dominant Mendelian disorder caused by mutation in the IKBKG/NEMO gene, encoding for NEMO/IKKgamma, a regulatory protein of nuclear factor kappaB (NF-kB) signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24339369", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 750, 
            "offsetInEndSection": 890, 
            "text": "Mutations in the NEMO gene give rise to a heterogeneous group of disorders, including the X-linked dominant disorder incontinentia pigmenti.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20499091", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1141, 
            "offsetInEndSection": 1218, 
            "text": "In patients with incontinenia pigmenti, mutations in the NEMO gene are found.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23378396", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1162, 
            "offsetInEndSection": 1332, 
            "text": "Mutations in the NEMO gene have been reported in association with hypohidrotic ectodermal dysplasia with immunodeficiency (HED-ID), OL-HED-ID, and incontinentia pigmenti.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23405946", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 113, 
            "text": "IKBKG/NEMO gene mutations cause an X-linked, dominant neuroectodermal disorder named Incontinentia Pigmenti (IP).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22121116", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 80, 
            "text": "[NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15833158", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1072, 
            "offsetInEndSection": 1148, 
            "text": "In patients with incontinenia pigmenti, mutations in the NEMO gene are found", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23378396", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 324, 
            "text": "Amorphic mutations in the NF- kappa B essential modulator (NEMO) cause X-dominant incontinentia pigmenti, which is lethal in males in utero, whereas hypomorphic mutations cause X-recessive anhidrotic ectodermal dysplasia with immunodeficiency, a complex developmental disorder and life-threatening primary immunodeficiency. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16532398", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 68, 
            "text": "NEMO gene mutations in Chinese patients with incontinentia pigmenti.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20434027", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 108, 
            "text": "De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19149237", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 328, 
            "text": "Mutations in the inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma (IKBKG), also called nuclear factor-kappaB (NF-kB) essential modulator (NEMO), gene are the most common single cause of incontinentia pigmenti (IP) in females and anhydrotic ectodermal dysplasia with immunodeficiency (EDA-ID) in males.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18350553", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 59, 
            "text": "NEMO/IKK gamma-deficient mice model incontinentia pigmenti.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10911992", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 527, 
            "offsetInEndSection": 884, 
            "text": "Germline mutations in two genes, NEMO and CYBB, have long been known to cause other human diseases-incontinentia pigmenti (IP) and anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (NEMO/IKKG), and X-linked chronic granulomatous disease (CGD) (CYBB)-but specific mutations in either of these two genes have recently been shown to cause XR-MSMD.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22236433", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 616, 
            "offsetInEndSection": 756, 
            "text": "Mutations in the NEMO gene give rise to a heterogeneous group of disorders, including the X-linked dominant disorder incontinentia pigmenti.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20499091", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 114, 
            "text": "IKBKG/NEMO gene mutations cause an X-linked, dominant neuroectodermal disorder named Incontinentia Pigmenti (IP).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22121116", 
            "endSection": "abstract"
        }
    ]
}